tiprankstipranks
Advertisement
Advertisement

ABSI Stock Latest News

Absci Corp. Earnings Call: Betting on ABS-201
Company AnnouncementsAbsci Corp. Earnings Call: Betting on ABS-201
17d ago
ABSI
Absci price target lowered to $4.20 from $4.32 at Morgan Stanley
PremiumThe Fly
Absci price target lowered to $4.20 from $4.32 at Morgan Stanley
18d ago
ABSI
Closing Bell Movers: KB Home slips on earnings miss
PremiumThe Fly
Closing Bell Movers: KB Home slips on earnings miss
19d ago
FPS
GME
Absci Reports 2025 Results and Advances ABS-201 Program
PremiumCompany Announcements
Absci Reports 2025 Results and Advances ABS-201 Program
19d ago
8K
ABSI
Absci reports Q4 EPS (20c), consensus (17c)
PremiumThe Fly
Absci reports Q4 EPS (20c), consensus (17c)
19d ago
ABSI
AbSci Corp options imply 13.4% move in share price post-earnings
PremiumThe FlyAbSci Corp options imply 13.4% move in share price post-earnings
19d ago
ABSI
Options Volatility and Implied Earnings Moves Today, March 24, 2026
Premium
Market News
Options Volatility and Implied Earnings Moves Today, March 24, 2026
19d ago
AIR
GME
Options Volatility and Implied Earnings Moves This Week, March 23 – March 27, 2026
Premium
Market News
Options Volatility and Implied Earnings Moves This Week, March 23 – March 27, 2026
20d ago
AIR
CCL
ABSI Earnings this Week: How Will it Perform?
PremiumPre-Earnings
ABSI Earnings this Week: How Will it Perform?
22d ago
ABSI
Absci Updates Leadership Indemnification Agreements Amid Governance Focus
PremiumCompany Announcements
Absci Updates Leadership Indemnification Agreements Amid Governance Focus
1M ago
8K
ABSI
Absci appoints Ransi Somaratne as CMO
PremiumThe Fly
Absci appoints Ransi Somaratne as CMO
1M ago
ABSI
VRTX
AMD discloses positions in Absci, Sanmina
PremiumThe Fly
AMD discloses positions in Absci, Sanmina
2M ago
AMD
ABSI
Absci Showcases Generative AI Drug Platform and Pipeline
PremiumCompany AnnouncementsAbsci Showcases Generative AI Drug Platform and Pipeline
3M ago
8K
ABSI
Absci downgraded to Equal Weight from Overweight at Morgan Stanley
Premium
The Fly
Absci downgraded to Equal Weight from Overweight at Morgan Stanley
3M ago
ABSI
AbSci’s ABS-201: Promising AGA Treatment with Key Milestones Ahead
Premium
Ratings
AbSci’s ABS-201: Promising AGA Treatment with Key Milestones Ahead
4M ago
ABSI
Absci price target raised to $8 from $7 at H.C. Wainwright
PremiumThe Fly
Absci price target raised to $8 from $7 at H.C. Wainwright
4M ago
ABSI
Promising Prospects for AbSci’s ABS-201 in Androgenetic Alopecia: Buy Rating Affirmed
PremiumRatings
Promising Prospects for AbSci’s ABS-201 in Androgenetic Alopecia: Buy Rating Affirmed
4M ago
ABSI
Absci’s ABS-201 shows efficacy in hair regeneration
PremiumThe Fly
Absci’s ABS-201 shows efficacy in hair regeneration
4M ago
ABSI
Absci, former U.S. soccer player Donovan announce partnership
PremiumThe Fly
Absci, former U.S. soccer player Donovan announce partnership
4M ago
ABSI
These 3 Under-the-Radar Stocks Have Triple-Digit Upside Potential – 12/5/2025
PremiumMarket NewsThese 3 Under-the-Radar Stocks Have Triple-Digit Upside Potential – 12/5/2025
4M ago
ABSI
GRPN
Promising Developments in AbSci’s ABS-201 Program and Market Potential
Premium
Ratings
Promising Developments in AbSci’s ABS-201 Program and Market Potential
4M ago
ABSI
Absci announces first participants dosed in Phase 1/2a HEADLINE trial
Premium
The Fly
Absci announces first participants dosed in Phase 1/2a HEADLINE trial
4M ago
ABSI

Trending

Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >